Showing results (1351-1360 of 2,286) with videos related to

Sort By:
Pageof 229
HIV Medicine|September 17, 2024
DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapyJoana Woods, Simiso Sokhela, Godspower Akpomiemie, et al.
HIV Medicine|September 15, 2024
Patient evaluation of Klick, a technology-enabled, nurse-delivered HIV outpatient pathwayS Day, C Rae, A McOwan, et al.
HIV Medicine|September 6, 2024
Real-world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV-1 aged over 50 years who are virologically suppressedC Piñeiro, S Policarpo, C Caldas, et al.
HIV Medicine|February 25, 2025
High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender women and people with a cervix living with perinatally acquired HIVMerle Henderson, Dierdre Lyons, Simon Beddows, et al.
HIV Medicine|February 14, 2025
The role of atherosclerosis in HIV-associated vasculopathy in young South African stroke patientsEitzaz Sadiq, Angela Woodiwiss, Grace Tade, et al.
HIV Medicine|September 2, 2024
Trajectories of CD4 T-cell count, CD8 T-cell count, and CD4/CD8 ratio in patients with HIV and long-term virological suppression based on Yunnan HIV cohortYuanlu Shu, Mi Zhang, Jianjian Li, et al.
HIV Medicine|June 26, 2024
The HepHIV 2023 Madrid conference: A call to action for political leadership in reaching the sustainable development goals on earlier testing and linkage to care for HIV, viral hepatitis, and sexually transmitted infectionsDaniel Simões, Dorthe Raben, Alejandro Bertó Moran, et al.
HIV Medicine|April 25, 2006
Intrathoracic fat in HIV-infected patientsJ L Blanco, A Biglia, E Martinez, et al.
HIV Medicine|April 25, 2006
Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individualsS Hopkins, J Lambourne, G Farrell, et al.
HIV Medicine|April 25, 2006
Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancyF Lyons, S Hopkins, B Kelleher, et al.
Pageof 229